Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
  1. 4 Planned sale Chief Legal Officer sold 8,148 shares at $16.60 ($135,253)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Planned sale Chief Financial Officer sold 14,055 shares at an average $16.60 ($233,319)
  11. 4 Planned sale Chief Legal Officer sold 8,148 shares at $16.96 ($138,210)
  12. 4 Planned sale Chief Legal Officer sold 5,394 shares at $16.76 ($90,407)
  13. 4 Open-market sale Chief Financial Officer sold 2,388 shares at $16.65 ($39,749)
  14. 4 Open-market sale Chief Legal Officer sold 3,214 shares at $16.65 ($53,498)
  15. 4 Open-market sale Chief Scientific Officer sold 3,214 shares at $16.65 ($53,498)
  16. 4 Planned sale Chief Legal Officer sold 8,148 shares at $15.24 ($124,149)
  17. 4 Planned sale Chief Legal Officer sold 8,148 shares at $15.44 ($125,793)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 14 · 274 filings